Search results
28 lis 2023 · The article argues that putting the specific needs of individuals and communities at the heart of HIV/AIDS care, by harnessing behavioural science, is key to building on the progress already been made. It cites Botswana as a model for reaching the 95-95-95 targets and highlights the challenges and opportunities for young people and other populations at risk.
2 wrz 2024 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
1 gru 2021 · An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years.
26 mar 2024 · A patented HIV-virus-like-particle (HLP) can effectively 'shock and kill' latent HIV reservoir in people living with chronic HIV on cART, according to a study by an international team of researchers. HLP is an affordable and injectable biotherapeutic that can target different HIV subtypes and reverse latency irrespective of infection duration.
10 lip 2024 · Lenacapavir is a long-acting injectable medicine that showed overwhelming efficacy for preventing HIV infections compared to oral PrEP in trials. UNAIDS urges Gilead to ensure equitable global access to this game-changing medicine through generic production and voluntary licensing agreements.
Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts DNA...
25 lip 2024 · The new case (1) presented at AIDS 2024 is a 60-year-old German man living with HIV who was diagnosed with acute myeloid leukaemia and underwent a blood stem cell transplant in 2015 from a donor with the CCR5-delta 32 mutation.
